Amrutanjan Health Care Statistics
Total Valuation
Amrutanjan Health Care has a market cap or net worth of INR 22.37 billion. The enterprise value is 20.28 billion.
Market Cap | 22.37B |
Enterprise Value | 20.28B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | Sep 13, 2024 |
Share Statistics
Amrutanjan Health Care has 28.91 million shares outstanding. The number of shares has decreased by -1.08% in one year.
Shares Outstanding | 28.91M |
Shares Change (YoY) | -1.08% |
Shares Change (QoQ) | -0.31% |
Owned by Insiders (%) | 24.12% |
Owned by Institutions (%) | 7.25% |
Float | 14.36M |
Valuation Ratios
The trailing PE ratio is 52.57.
PE Ratio | 52.57 |
Forward PE | n/a |
PS Ratio | 5.24 |
PB Ratio | 7.76 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 47.63 |
EV / Sales | 4.75 |
EV / EBITDA | 41.80 |
EV / EBIT | 48.34 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.04 |
Debt / FCF | n/a |
Interest Coverage | 212.51 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 9.01% |
Revenue Per Employee | 6.74M |
Profits Per Employee | 671,505 |
Employee Count | 634 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.59% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +24.59% |
50-Day Moving Average | 778.82 |
200-Day Moving Average | 702.07 |
Relative Strength Index (RSI) | 48.83 |
Average Volume (20 Days) | 32,681 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amrutanjan Health Care had revenue of INR 4.27 billion and earned 425.73 million in profits. Earnings per share was 14.72.
Revenue | 4.27B |
Gross Profit | 2.12B |
Operating Income | 419.49M |
Pretax Income | 588.65M |
Net Income | 425.73M |
EBITDA | 485.17M |
EBIT | 419.49M |
Earnings Per Share (EPS) | 14.72 |
Balance Sheet
The company has 2.11 billion in cash and 17.28 million in debt, giving a net cash position of 2.10 billion or 72.49 per share.
Cash & Cash Equivalents | 2.11B |
Total Debt | 17.28M |
Net Cash | 2.10B |
Net Cash Per Share | 72.49 |
Equity (Book Value) | 2.88B |
Book Value Per Share | 99.69 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 49.61%, with operating and profit margins of 9.82% and 9.97%.
Gross Margin | 49.61% |
Operating Margin | 9.82% |
Pretax Margin | 13.78% |
Profit Margin | 9.97% |
EBITDA Margin | 11.36% |
EBIT Margin | 9.82% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.60, which amounts to a dividend yield of 0.59%.
Dividend Per Share | 4.60 |
Dividend Yield | 0.59% |
Dividend Growth (YoY) | -21.74% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.08% |
Shareholder Yield | 1.68% |
Earnings Yield | 1.90% |
FCF Yield | n/a |
Stock Splits
The last stock split was on April 13, 2018. It was a forward split with a ratio of 2.
Last Split Date | Apr 13, 2018 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |